Accelerating progress in induced pluripotent stem cell research for neurological diseases
Daisuke Ito1, Hideyuki Okano, Norihiro Suzuki
1Departments of Neurology, School of Medicine, Keio University, Tokyo, Japan. d-ito@jk9.so-net.ne.jp
Annals of Neurology
|August 29, 2012
Summary
Induced pluripotent stem cells (iPSCs) offer a powerful tool for studying neurodegenerative diseases. Patient-derived iPSCs enable disease modeling, aiding drug discovery and regenerative medicine approaches.
Area of Science:
- Stem Cell Biology
- Neuroscience
- Genetics
Background:
- Induced pluripotent stem cells (iPSCs) are generated from somatic cells using specific transcription factors.
- iPSCs possess pluripotency comparable to embryonic stem cells.
- Patient-derived iPSCs are valuable for modeling neurological diseases, including late-onset conditions.
Purpose of the Study:
- To review the current progress in neurodegenerative disease research utilizing iPSCs.
- To discuss the potential applications of iPSCs in understanding disease pathology.
- To explore the role of iPSCs in drug discovery and regenerative medicine for neurological disorders.
Main Methods:
- Reprogramming of somatic cells into iPSCs.
- Generation of patient-derived iPSCs.
- Utilizing iPSCs for disease modeling and pathological studies.
Main Results:
- iPSCs provide a platform for recapitulating neurological disease phenotypes in vitro.
- Patient-derived iPSCs enhance understanding of neurodegenerative disease pathogenesis.
- iPSCs are emerging as a key resource for disease-specific neural cell generation.
Conclusions:
- iPSCs hold significant promise for advancing neurodegenerative disease research.
- iPSCs can facilitate the elucidation of pathological processes in neurodegenerative diseases.
- The application of iPSCs is expected to accelerate drug discovery and regenerative therapies for neurological conditions.
More Related Videos
Related Concept Videos
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.


